Rankings
▼
Calendar
NTRA Q2 2018 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena
NTRA
Natera, Inc.
$28B
Q2 2018 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$63M
+17.6% YoY
Gross Profit
$22M
35.0% margin
Operating Income
-$27M
-43.2% margin
Net Income
-$34M
-53.6% margin
EPS (Diluted)
$-0.62
QoQ Revenue Growth
+1.2%
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$36M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$194M
Total Liabilities
$216M
Stockholders' Equity
-$22M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$63M
$54M
+17.6%
Gross Profit
$22M
$19M
+15.8%
Operating Income
-$27M
-$27M
-0.7%
Net Income
-$34M
-$28M
-22.0%
Revenue Segments
Product
$60M
48%
Panorama Nipt
$36M
28%
Hcs
$21M
17%
Other Genetic Tests
$3M
3%
Licensing And Other
$3M
2%
Other Licensing And Other
$1M
1%
Constellation
$1M
1%
Geographic Segments
U
$57M
90%
E M E A
$4M
6%
X
$2M
3%
Americas Excluding Us
$847,000
1%
← FY 2018
All Quarters
Q3 2018 →